AC: Clinical Trials

3 trials of AC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow AC: new trials by email Literature Review of AC trials Research Report on AC

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling
Peer Engagement and Exploration of Responsibility and Safety, Active Control - Suicide, Secure Firearm Storage
Phase 1 / Phase 2Not yet recruitingVA Office of Research and Development1002027-02-012026-10-26
A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Ipatasertib, Paclitaxel, Atezolizumab - Breast Cancer
Phase 1CompletedHoffmann-La Roche1392018-02-132024-10-30
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
Azacitidine Injection, sodium phenylbutyrate - Lymphoma, Small Intestine Cancer
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins342000-03-012019-01-11

Conditions studied

Breast Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Large-Cell, Immunoblastic (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell, Cutaneous (1)

Sponsors

Hoffmann-La Roche (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  VA Office of Research and Development (1)

Countries

United States (3)  ·  Australia (1)  ·  France (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Claire Houtsma, PhD (1)  ·  Michael A. Carducci, MD (1)

Results publications

PMID 19789320, PMID 38060199

NIH funding

1IK2CX002877-01A1 (1), 2017 (1), P30CA006973 (1), P50CA058236 (1), R01CA075525 (1), U01CA070095 (1)